{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:00:32Z","timestamp":1780682432287,"version":"3.54.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1D1A3B05041889, RS-2023-00240942, and RS-2024-00462450"],"award-info":[{"award-number":["2018R1D1A3B05041889, RS-2023-00240942, and RS-2024-00462450"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02690-9","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:00:45Z","timestamp":1780675245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Gdf15-xenobiotic receptor axis shapes NK cell maladaptation predicting cold tumors under environmental stress"],"prefix":"10.1038","volume":"11","author":[{"given":"Juil","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoyoung","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Joon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Hoon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8686-8166","authenticated-orcid":false,"given":"Yuseok","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"2690_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10549-006-9416-4","volume":"104","author":"MZ Dewan","year":"2007","unstructured":"Dewan, M. Z. et al. Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo. Breast Cancer Res. Treat. 104, 267\u2013275 (2007).","journal-title":"Breast Cancer Res. Treat."},{"key":"2690_CR2","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.3389\/fimmu.2017.01825","volume":"8","author":"LD Uppendahl","year":"2017","unstructured":"Uppendahl, L. D., Dahl, C. M., Miller, J. S., Felices, M. & Geller, M. A. Natural killer cell-based immunotherapy in gynecologic malignancy: a review. Front Immunol. 8, 1825 (2017).","journal-title":"Front Immunol."},{"key":"2690_CR3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/eji.201747289","volume":"48","author":"UY Moreno-Nieves","year":"2018","unstructured":"Moreno-Nieves, U. Y., Mundy, D. C., Shin, J. H., Tam, K. & Sunwoo, J. B. The aryl hydrocarbon receptor modulates the function of human CD56(bright) NK cells. Eur. J. Immunol. 48, 771\u2013776 (2018).","journal-title":"Eur. J. Immunol."},{"key":"2690_CR4","doi-asserted-by":"publisher","first-page":"12391","DOI":"10.1073\/pnas.1302856110","volume":"110","author":"JH Shin","year":"2013","unstructured":"Shin, J. H. et al. Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 110, 12391\u201312396 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2690_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44789-z","volume":"15","author":"I Dean","year":"2024","unstructured":"Dean, I. et al. Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity. Nat. Commun. 15, 683 (2024).","journal-title":"Nat. Commun."},{"key":"2690_CR6","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41590-024-01883-0","volume":"25","author":"L Rebuffet","year":"2024","unstructured":"Rebuffet, L. et al. High-dimensional single-cell analysis of human natural killer cell heterogeneity. Nat. Immunol. 25, 1474\u20131488 (2024).","journal-title":"Nat. Immunol."},{"key":"2690_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2174\/138920011795016818","volume":"12","author":"L Stejskalova","year":"2011","unstructured":"Stejskalova, L., Dvorak, Z. & Pavek, P. Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art. Curr. Drug Metab. 12, 198\u2013212 (2011).","journal-title":"Curr. Drug Metab."},{"key":"2690_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0542-9","volume":"9","author":"B Yan","year":"2018","unstructured":"Yan, B. et al. Activation of AhR with nuclear IKKalpha regulates cancer stem-like properties in the occurrence of radioresistance. Cell Death Dis. 9, 490 (2018).","journal-title":"Cell Death Dis."},{"key":"2690_CR9","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.3390\/ijms23126395","volume":"23","author":"L Therachiyil","year":"2022","unstructured":"Therachiyil, L. et al. Aryl hydrocarbon receptor promotes cell growth, stemness-like characteristics, and metastasis in human ovarian cancer via activation of pi3k\/akt, beta-catenin, and epithelial to mesenchymal transition pathways. Int. J. Mol. Sci. 23, 6395 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2690_CR10","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.3390\/ijms20122862","volume":"20","author":"E Deuster","year":"2019","unstructured":"Deuster, E. et al. Correlation of the aryl hydrocarbon receptor with fshr in ovarian cancer patients. Int. J. Mol. Sci. 20, 2862 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"2690_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11864-018-0584-3","volume":"19","author":"CA Fan","year":"2018","unstructured":"Fan, C. A., Reader, J. & Roque, D. M. Review of immune therapies targeting ovarian cancer. Curr. Treat. Options Oncol. 19, 74 (2018).","journal-title":"Curr. Treat. Options Oncol."},{"key":"2690_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/cancers10090295","volume":"10","author":"Y Klymenko","year":"2018","unstructured":"Klymenko, Y. & Nephew, K. P. Epigenetic crosstalk between the tumor microenvironment and ovarian cancer cells: a therapeutic road less traveled. Cancers (Basel) 10, 295 (2018).","journal-title":"Cancers (Basel)"},{"key":"2690_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5528\/wjtm.v3.i1.1","volume":"3","author":"A Desai","year":"2014","unstructured":"Desai, A. et al. Epithelial ovarian cancer: an overview. World J. Transl. Med. 3, 1\u20138 (2014).","journal-title":"World J. Transl. Med."},{"key":"2690_CR14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.ogc.2007.09.008","volume":"34","author":"C Vo","year":"2007","unstructured":"Vo, C. & Carney, M. E. Ovarian cancer hormonal and environmental risk effect. Obstet. Gynecol. Clin. North Am. 34, 687\u2013700 (2007).","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"2690_CR15","first-page":"640","volume":"118","author":"E Zudaire","year":"2008","unstructured":"Zudaire, E. et al. The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers. J. Clin. Invest. 118, 640\u2013650 (2008).","journal-title":"J. Clin. Invest."},{"key":"2690_CR16","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/IGC.0b013e31828bdbb6","volume":"23","author":"JL Alcazar","year":"2013","unstructured":"Alcazar, J. L., Utrilla-Layna, J., Minguez, J. A. & Jurado, M. Clinical and ultrasound features of type I and type II epithelial ovarian cancer. Int. J. Gynecol. Cancer 23, 680\u2013684 (2013).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"2690_CR17","first-page":"461","volume":"37","author":"M Biedka","year":"2016","unstructured":"Biedka, M. The outcomes of radiotherapy in patients with ovarian carcinoma. Eur. J. Gynecol. Oncol. 37, 461\u2013468 (2016).","journal-title":"Eur. J. Gynecol. Oncol."},{"key":"2690_CR18","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1055\/a-1128-0280","volume":"80","author":"C Claussen","year":"2020","unstructured":"Claussen, C., Rody, A. & Hanker, L. Treatment of recurrent epithelial ovarian cancer. Geburtshilfe Frauenheilkd. 80, 1195\u20131204 (2020).","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"2690_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4161\/cbt.11.8.14967","volume":"11","author":"G Mor","year":"2011","unstructured":"Mor, G., Yin, G., Chefetz, I., Yang, Y. & Alvero, A. Ovarian cancer stem cells and inflammation. Cancer Biol. Ther. 11, 708\u2013713 (2011).","journal-title":"Cancer Biol. Ther."},{"key":"2690_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fimmu.2018.00186","volume":"9","author":"Z Du","year":"2018","unstructured":"Du, Z., Kim, K. H., Kim, J. & Moon, Y. Fungal deoxynivalenol-induced enterocyte distress is attenuated by adulterated adlay: in vitro evidence for mucoactive counteraction. Front Immunol. 9, 186 (2018).","journal-title":"Front Immunol."},{"key":"2690_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4246-4","volume":"18","author":"D Zhao","year":"2018","unstructured":"Zhao, D., Wang, X. & Zhang, W. GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer. BMC Cancer 18, 328 (2018).","journal-title":"BMC Cancer"},{"key":"2690_CR22","doi-asserted-by":"publisher","first-page":"72148","DOI":"10.18632\/oncotarget.12355","volume":"7","author":"KH Kim","year":"2016","unstructured":"Kim, K. H. et al. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells. Oncotarget 7, 72148\u201372166 (2016).","journal-title":"Oncotarget"},{"key":"2690_CR23","first-page":"4785","volume":"33","author":"S Furukawa","year":"2013","unstructured":"Furukawa, S. et al. MCP-1 promotes invasion and adhesion of human ovarian cancer cells. Anticancer Res. 33, 4785\u20134790 (2013).","journal-title":"Anticancer Res."},{"key":"2690_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1182\/blood.V96.1.34","volume":"96","author":"R Salcedo","year":"2000","unstructured":"Salcedo, R. et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96, 34\u201340 (2000).","journal-title":"Blood"},{"key":"2690_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000473891","volume":"83","author":"CA Lima","year":"2018","unstructured":"Lima, C. A. et al. Stromal growth differentiation factor 15 and its association with ovarian cancer. Gynecol. Obstet. Invest. 83, 35\u201339 (2018).","journal-title":"Gynecol. Obstet. Invest."},{"key":"2690_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1089\/107999003322277829","volume":"23","author":"CM Robinson","year":"2003","unstructured":"Robinson, C. M., Shirey, K. A. & Carlin, J. M. Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alpha. J. Interferon Cytokine Res. 23, 413\u2013421 (2003).","journal-title":"J. Interferon Cytokine Res."},{"key":"2690_CR27","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1182\/blood-2006-11-056010","volume":"110","author":"SW Tas","year":"2007","unstructured":"Tas, S. W. et al. Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. Blood 110, 1540\u20131549 (2007).","journal-title":"Blood"},{"key":"2690_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fimmu.2016.00091","volume":"7","author":"H Klingemann","year":"2016","unstructured":"Klingemann, H., Boissel, L. & Toneguzzo, F. Natural killer cells for immunotherapy - advantages of the NK-92 cell line over blood NK cells. Front Immunol. 7, 91 (2016).","journal-title":"Front Immunol."},{"key":"2690_CR29","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","volume":"196","author":"T Michel","year":"2016","unstructured":"Michel, T. et al. Human CD56bright NK cells: an update. J. Immunol. 196, 2923\u20132931 (2016).","journal-title":"J. Immunol."},{"key":"2690_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1615\/CritRevImmunol.2021037643","volume":"41","author":"D Wang","year":"2021","unstructured":"Wang, D. et al. Role of GATA2 in human NK cell development. Crit. Rev. Immunol. 41, 21\u201333 (2021).","journal-title":"Crit. Rev. Immunol."},{"key":"2690_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.73","volume":"48","author":"DK Kim","year":"2016","unstructured":"Kim, D. K. et al. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells. Exp. Mol. Med 48, e255 (2016).","journal-title":"Exp. Mol. Med"},{"key":"2690_CR32","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"2690_CR33","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich, J. D. et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 185, 3190\u20133198 (2010).","journal-title":"J. Immunol."},{"key":"2690_CR34","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1182\/blood-2009-09-246124","volume":"115","author":"X Liu","year":"2010","unstructured":"Liu, X. et al. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity. Blood 115, 3520\u20133530 (2010).","journal-title":"Blood"},{"key":"2690_CR35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.imbio.2010.07.010","volume":"216","author":"B Sperner-Unterweger","year":"2011","unstructured":"Sperner-Unterweger, B. et al. Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers. Immunobiology 216, 296\u2013301 (2011).","journal-title":"Immunobiology"},{"key":"2690_CR36","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1182\/blood-2006-03-006700","volume":"108","author":"M Chiesa","year":"2006","unstructured":"Chiesa, M. et al. The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function. Blood 108, 4118\u20134125 (2006).","journal-title":"Blood"},{"key":"2690_CR37","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.intimp.2011.02.005","volume":"11","author":"H Song","year":"2011","unstructured":"Song, H. et al. L-kynurenine-induced apoptosis in human NK cells is mediated by reactive oxygen species. Int. Immunopharmacol. 11, 932\u2013938 (2011).","journal-title":"Int. Immunopharmacol."},{"key":"2690_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1615\/CritRevEukarGeneExpr.v18.i3.20","volume":"18","author":"TV Beischlag","year":"2008","unstructured":"Beischlag, T. V., Luis Morales, J., Hollingshead, B. D. & Perdew, G. H. The aryl hydrocarbon receptor complex and the control of gene expression. Crit. Rev. Eukaryot. Gene Expr. 18, 207\u2013250 (2008).","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"2690_CR39","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fimmu.2018.00286","volume":"9","author":"P Xue","year":"2018","unstructured":"Xue, P., Fu, J. & Zhou, Y. The aryl hydrocarbon receptor and tumor immunity. Front. Immunol. 9, 286 (2018).","journal-title":"Front. Immunol."},{"key":"2690_CR40","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1182\/blood-2012-09-453969","volume":"121","author":"EM Mace","year":"2013","unstructured":"Mace, E. M. et al. Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. Blood 121, 2669\u20132677 (2013).","journal-title":"Blood"},{"key":"2690_CR41","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1533-869X.2003.01108.x","volume":"3","author":"S Kai","year":"2003","unstructured":"Kai, S. et al. Inhibition of indoleamine 2,3-dioxygenase suppresses NK cell activity and accelerates tumor growth. J. Exp. Ther. Oncol. 3, 336\u2013345 (2003).","journal-title":"J. Exp. Ther. Oncol."},{"key":"2690_CR42","first-page":"6996","volume":"61","author":"P Buckhaults","year":"2001","unstructured":"Buckhaults, P. et al. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res. 61, 6996\u20137001 (2001).","journal-title":"Cancer Res."},{"key":"2690_CR43","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1073\/pnas.0530278100","volume":"100","author":"JB Welsh","year":"2003","unstructured":"Welsh, J. B. et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc. Natl. Acad. Sci. USA 100, 3410\u20133415 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2690_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ijc.1291","volume":"93","author":"R Thomas","year":"2001","unstructured":"Thomas, R., True, L. D., Lange, P. H. & Vessella, R. L. Placental bone morphogenetic protein (PLAB) gene expression in normal, premalignant and malignant human prostate: relation to tumor development and progression. Int. J. Cancer 93, 47\u201352 (2001).","journal-title":"Int. J. Cancer"},{"key":"2690_CR45","first-page":"2642","volume":"9","author":"DA Brown","year":"2003","unstructured":"Brown, D. A. et al. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin. Cancer Res. 9, 2642\u20132650 (2003).","journal-title":"Clin. Cancer Res."},{"key":"2690_CR46","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1158\/0008-5472.CAN-05-3433","volume":"66","author":"CF Basil","year":"2006","unstructured":"Basil, C. F. et al. Common cancer biomarkers. Cancer Res. 66, 2953\u20132961 (2006).","journal-title":"Cancer Res."},{"key":"2690_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1667\/RR3492.1","volume":"165","author":"R Okazaki","year":"2006","unstructured":"Okazaki, R., Moon, Y., Norimura, T. & Eling, T. Ionizing radiation enhances the expression of the nonsteroidal anti-inflammatory drug-activated gene (NAG1) by increasing the expression of TP53 in human colon cancer cells. Radiat. Res. 165, 125\u2013130 (2006).","journal-title":"Radiat. Res."},{"key":"2690_CR48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.lfs.2014.01.075","volume":"100","author":"MH Yang","year":"2014","unstructured":"Yang, M. H., Kim, J., Khan, I. A., Walker, L. A. & Khan, S. I. Nonsteroidal anti-inflammatory drug activated gene-1 (NAG-1) modulators from natural products as anticancer agents. Life Sci. 100, 75\u201384 (2014).","journal-title":"Life Sci."},{"key":"2690_CR49","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1089\/ars.2012.4963","volume":"20","author":"P Chaudhari","year":"2014","unstructured":"Chaudhari, P., Ye, Z. & Jang, Y. Y. Roles of reactive oxygen species in the fate of stem cells. Antioxid. Redox Signal 20, 1881\u20131890 (2014).","journal-title":"Antioxid. Redox Signal"},{"key":"2690_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.50","volume":"4","author":"K Wang","year":"2013","unstructured":"Wang, K. et al. Redox homeostasis: the linchpin in stem cell self-renewal and differentiation. Cell Death Dis. 4, e537 (2013).","journal-title":"Cell Death Dis."},{"key":"2690_CR51","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.18632\/oncotarget.13649","volume":"8","author":"YL Li","year":"2017","unstructured":"Li, Y. L. et al. GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway. Oncotarget 8, 1508\u20131528 (2017).","journal-title":"Oncotarget"},{"key":"2690_CR52","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.bbrc.2020.01.148","volume":"524","author":"Y Ozawa","year":"2020","unstructured":"Ozawa, Y. et al. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells. Biochem. Biophys. Res. Commun. 524, 723\u2013729 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2690_CR53","doi-asserted-by":"publisher","first-page":"860","DOI":"10.18632\/oncotarget.6205","volume":"7","author":"C Li","year":"2016","unstructured":"Li, C. et al. GDF15 promotes EMT and metastasis in colorectal cancer. Oncotarget 7, 860\u2013872 (2016).","journal-title":"Oncotarget"},{"key":"2690_CR54","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.canlet.2007.11.020","volume":"261","author":"JH Kim","year":"2008","unstructured":"Kim, J. H. et al. Adipocyte culture medium stimulates production of macrophage inhibitory cytokine 1 in MDA-MB-231 cells. Cancer Lett. 261, 253\u2013262 (2008).","journal-title":"Cancer Lett."},{"key":"2690_CR55","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.1038\/onc.2012.508","volume":"32","author":"HJ Choi","year":"2013","unstructured":"Choi, H. J., Kim, J., Do, K. H., Park, S. H. & Moon, Y. Enteropathogenic Escherichia coli-induced macrophage inhibitory cytokine 1 mediates cancer cell survival: an in vitro implication of infection-linked tumor dissemination. Oncogene 32, 4960\u20134969 (2013).","journal-title":"Oncogene"},{"key":"2690_CR56","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ebiom.2019.04.018","volume":"43","author":"H Kleinertz","year":"2019","unstructured":"Kleinertz, H. et al. Circulating growth\/differentiation factor 15 is associated with human CD56(bright) natural killer cell dysfunction and nosocomial infection in severe systemic inflammation. EBioMedicine 43, 380\u2013391 (2019).","journal-title":"EBioMedicine"},{"key":"2690_CR57","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fimmu.2020.00311","volume":"11","author":"S Regis","year":"2020","unstructured":"Regis, S., Dondero, A., Caliendo, F., Bottino, C. & Castriconi, R. NK cell function regulation by TGF-beta-induced epigenetic mechanisms. Front Immunol. 11, 311 (2020).","journal-title":"Front Immunol."},{"key":"2690_CR58","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1158\/0008-5472.CAN-05-3948","volume":"66","author":"MG Kelly","year":"2006","unstructured":"Kelly, M. G. et al. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res. 66, 3859\u20133868 (2006).","journal-title":"Cancer Res."},{"key":"2690_CR59","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4161\/cc.8.1.7533","volume":"8","author":"AB Alvero","year":"2009","unstructured":"Alvero, A. B. et al. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 8, 158\u2013166 (2009).","journal-title":"Cell Cycle"},{"key":"2690_CR60","first-page":"42","volume":"42","author":"YY Jang","year":"2012","unstructured":"Jang, Y. Y. et al. An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells. Ann. Clin. Lab Sci. 42, 42\u201349 (2012).","journal-title":"Ann. Clin. Lab Sci."},{"key":"2690_CR61","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0021-9673(00)89443-1","volume":"175","author":"S Yong","year":"1979","unstructured":"Yong, S. & Lau, S. Rapid separation of tryptophan, kynurenines, and indoles using reversed-phase high-performance liquid chromatography. J. Chromatogr. 175, 343\u2013346 (1979).","journal-title":"J. Chromatogr."},{"key":"2690_CR62","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2005-03-0979","volume":"106","author":"D Braun","year":"2005","unstructured":"Braun, D., Longman, R. S. & Albert, M. L. A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood 106, 2375\u20132381 (2005).","journal-title":"Blood"},{"key":"2690_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2021.113130","volume":"230","author":"Y Moon","year":"2021","unstructured":"Moon, Y., Korcsmaros, T., Nagappan, A. & Ray, N. MicroRNA target-based network predicts androgen receptor-linked mycotoxin stress. Ecotoxicol. Environ. Saf. 230, 113130 (2021).","journal-title":"Ecotoxicol. Environ. Saf."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02690-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:04:02Z","timestamp":1780679042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02690-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2690"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02690-9","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"21 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"219"}}